LU80937A1 - Nouveaux amides derives d'acides carboxyliques-5 pyrimidiniques,leur preparation et leur application en therapeutique - Google Patents

Nouveaux amides derives d'acides carboxyliques-5 pyrimidiniques,leur preparation et leur application en therapeutique

Info

Publication number
LU80937A1
LU80937A1 LU80937A LU80937A LU80937A1 LU 80937 A1 LU80937 A1 LU 80937A1 LU 80937 A LU80937 A LU 80937A LU 80937 A LU80937 A LU 80937A LU 80937 A1 LU80937 A1 LU 80937A1
Authority
LU
Luxembourg
Prior art keywords
pyrimidinic
therapeutics
carboxylic
acids
preparation
Prior art date
Application number
LU80937A
Other languages
English (en)
French (fr)
Inventor
T Imbert
J Ancher
B Bucher
Original Assignee
Delalande Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR7804921A external-priority patent/FR2417506A1/fr
Priority claimed from FR7902286A external-priority patent/FR2457286A2/fr
Application filed by Delalande Sa filed Critical Delalande Sa
Publication of LU80937A1 publication Critical patent/LU80937A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/30Halogen atoms or nitro radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • C07D239/34One oxygen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • C07D239/34One oxygen atom
    • C07D239/36One oxygen atom as doubly bound oxygen atom or as unsubstituted hydroxy radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • C07D239/38One sulfur atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Anesthesiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
LU80937A 1978-02-21 1979-02-19 Nouveaux amides derives d'acides carboxyliques-5 pyrimidiniques,leur preparation et leur application en therapeutique LU80937A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR7804921A FR2417506A1 (fr) 1978-02-21 1978-02-21 Nouveaux amides derives d'acides carboxyliques-5 pyrimidiniques utiles notamment dans le traitement des troubles du psychisme
FR7902286A FR2457286A2 (fr) 1979-01-30 1979-01-30 Nouveaux amides derives d'acides carboxyliques-5 pyrimidiniques, leur preparation et leur application en therapeutique

Publications (1)

Publication Number Publication Date
LU80937A1 true LU80937A1 (fr) 1979-10-29

Family

ID=26220449

Family Applications (1)

Application Number Title Priority Date Filing Date
LU80937A LU80937A1 (fr) 1978-02-21 1979-02-19 Nouveaux amides derives d'acides carboxyliques-5 pyrimidiniques,leur preparation et leur application en therapeutique

Country Status (13)

Country Link
US (1) US4250178A (sv)
JP (1) JPS54130585A (sv)
AU (1) AU526298B2 (sv)
CA (1) CA1096868A (sv)
CH (1) CH639078A5 (sv)
DE (1) DE2906461A1 (sv)
ES (1) ES477852A1 (sv)
GB (1) GB2014984B (sv)
GR (1) GR66581B (sv)
IT (1) IT1113438B (sv)
LU (1) LU80937A1 (sv)
NL (1) NL7901333A (sv)
SE (1) SE446450B (sv)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2133004B (en) * 1982-11-04 1986-06-11 Ici Plc Process for the extraction of metal values and novel metal extractants
US4743605A (en) * 1987-02-24 1988-05-10 Warner-Lambert Company Saturated fatty acid amides as inhibitors of acyl-coa:cholesterol acyltransferase
DE4425143A1 (de) * 1994-07-15 1996-01-18 Basf Ag Substituierte Pyrimidinverbindungen und deren Verwendung
EP0850228A1 (en) * 1995-09-01 1998-07-01 Signal Pharmaceuticals, Inc. Pyrimidine carboxamides and related compounds and methods for treating inflammatory conditions
US5811428A (en) * 1995-12-18 1998-09-22 Signal Pharmaceuticals, Inc. Pyrimidine carboxamides and related compounds and methods for treating inflammatory conditions
DE69828197T2 (de) * 1997-10-27 2005-12-08 Sumitomo Pharmaceuticals Co., Ltd. Amidderivate zur behandlung neurodegenerativer erkrankungen der netzhaut
US7504396B2 (en) * 2003-06-24 2009-03-17 Amgen Inc. Substituted heterocyclic compounds and methods of use
TW200827346A (en) * 2006-11-03 2008-07-01 Astrazeneca Ab Chemical compounds
TW200836719A (en) * 2007-02-12 2008-09-16 Astrazeneca Ab Chemical compounds
WO2009098501A1 (en) * 2008-02-04 2009-08-13 Astrazeneca Ab Novel crystalline forms of 4- [4- (2-adamantylcarbam0yl) -5-tert-butyl-pyrazol-1-yl] benzoic acid
CN102066335A (zh) * 2008-04-22 2011-05-18 阿斯利康(瑞典)有限公司 取代的嘧啶-5-甲酰胺281
AU2015315177A1 (en) * 2014-09-10 2017-03-16 Epizyme, Inc. Substituted pyrrolidine carboxamide compounds

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2789979A (en) * 1954-09-22 1957-04-23 Searle & Co Basically substituted nu-alkyl-2-amino-4-hydroxy-5-pyrimidine carboxamides and salts thereof

Also Published As

Publication number Publication date
AU4439279A (en) 1979-07-19
GR66581B (sv) 1981-03-27
SE446450B (sv) 1986-09-15
IT7920206A0 (it) 1979-02-15
NL7901333A (nl) 1979-08-23
GB2014984A (en) 1979-09-05
DE2906461A1 (de) 1979-08-23
US4250178A (en) 1981-02-10
IT1113438B (it) 1986-01-20
CH639078A5 (fr) 1983-10-31
CA1096868A (en) 1981-03-03
GB2014984B (en) 1982-06-09
SE7901493L (sv) 1979-08-22
JPS54130585A (en) 1979-10-09
ES477852A1 (es) 1979-08-01
AU526298B2 (en) 1983-01-06

Similar Documents

Publication Publication Date Title
BE874202A (fr) Derives d'iminoacides cycliques et leur preparation
FR2617170B1 (fr) Nouveaux derives peptidiques et leur application notamment en therapeutique
BE891797A (fr) Nouveaux derives de la furo- (3,4-c)-pyridine, leur preparation et leur emploi therapeutique
LU80937A1 (fr) Nouveaux amides derives d'acides carboxyliques-5 pyrimidiniques,leur preparation et leur application en therapeutique
BE864632A (fr) Nouveaux derives d'acides phenoxy-alpha-phenoxy-alcanecarboxyliques, leur preparation et leur application comme herbicides
BE896572A (fr) Benzoazacycloalkyl-spiro-imidazolidines leur preparation et leur application en therapeutique
FR2543140B1 (fr) Nouveaux acides flavone-carboxyliques-4', leur methode de preparation et leur application en therapeutique
BE876238A (fr) Derives d'isopropylbenzene et leur preparation
BE844343A (fr) Nouveaux derives phenoxy,leur procede de preparation et leur application en therapeutique
BE888417A (fr) Nouveaux derives de theophyllinylmethyldioxolane, leur procedes de preparation et leur application en therapeutique,
BE857994A (fr) Acides dihydro-oxo-nicotiniques leur preparation et leur application en therapeutique
FR2608160B1 (fr) Nouveaux derives peptidiques et leur application notamment en therapeutique
BE879787A (fr) Nouveaux aryltrifluoroethanols, leur procede d'obtention et leur emploi en therapeutique
FR2352783A1 (fr) Derives polyprenyl-carboxyliques, leur procede de preparation et leur application en therapeutique
FR2352804A1 (fr) 4-quinazolinyl-guanidines, leur preparation et leur application en therapeutique
BE861500R (fr) Nouveaux derives d'isoxazoles, leur procde de preparation et leur applications
BE874266A (fr) Nouveaux amides derives d'acides carboxyliques-5 pyrimidiniques, leur preparation et leur application en therapeutique
FR2542744B2 (fr) 3',5'-diarabinosides, leur preparation et leur application en therapeutique
FR2341568A1 (fr) Nouveaux d'homo-steroides et leur procede de preparation
BE887430A (fr) Nouveaux derives de l'indane, leur preparation et leur application en therapeutique
FR2541994B1 (fr) Nouveaux derives d'ester phenylacetique, leur procede de preparation et leur application en therapeutique
BE848489A (fr) Halogenures d'acides sulfamiques et leur preparation,
BE867776R (fr) Derives d'acides thiazolidinecarboxyliques, leur preparation et leur application
MA19065A1 (fr) Nouveaux derives d'amino - 2 phenethylamines et leur preparation .
PT72247B (fr) Procede de preparation de nouveaux derives de l'amino-1 propanol-2 et leur application en therapeutique